70478-63-6 Usage
Uses
Used in Organic Synthesis:
4-Bromoisoindoline-1,3-dione is utilized as a reagent in organic synthesis for its ability to contribute to the formation of a wide range of chemical compounds. Its unique structure allows it to participate in multiple types of chemical reactions, making it a valuable component in the creation of new organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 4-Bromoisoindoline-1,3-dione is used as a precursor in the development of new drugs. Its potential applications in this field are supported by its demonstrated antibacterial and antifungal properties, which suggest its use in the creation of novel antimicrobial agents.
Used in Material and Dye Development:
4-Bromoisoindoline-1,3-dione is also employed in the development of new materials and dyes due to its chemical properties and reactivity. Its involvement in these applications is driven by the need for innovative materials with specific characteristics, such as colorfastness in dyes or unique physical properties in materials.
Overall, 4-Bromoisoindoline-1,3-dione's diverse applications and potential as a research tool underscore its importance in various scientific and industrial fields.
Check Digit Verification of cas no
The CAS Registry Mumber 70478-63-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,4,7 and 8 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 70478-63:
(7*7)+(6*0)+(5*4)+(4*7)+(3*8)+(2*6)+(1*3)=136
136 % 10 = 6
So 70478-63-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H4BrNO2/c9-5-3-1-2-4-6(5)8(12)10-7(4)11/h1-3H,(H,10,11,12)
70478-63-6Relevant academic research and scientific papers
FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF
-
, (2021/02/12)
The present invention provides compounds, compositions thereof, and methods of using the same. The present invention also relates to compounds and methods useful for binding and modulating the activity of cereblon (CRBN), especially for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK 1) INHIBITOR COMPOUNDS
-
Paragraph 00291, (2019/04/27)
Described herein are ASK1 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with ASK1 activity.